Hormonal Regulation and Hypertension
Hormonal Regulation and Hypertension is a research topic within Endocrinology, Diabetes and Metabolism. Science Explorer counts 50k research works in it since 1950. 17.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the management, diagnosis, and treatment of Primary Aldosteronism, a condition characterized by the overproduction of aldosterone by the adrenal glands. The research covers topics such as case detection, cardiovascular events, glucocorticoid and mineralocorticoid receptor actions, hypertension, and the use of spironolactone therapy. Additionally, it explores the association with metabolic syndrome and renal injury.
- Primary Aldosteronism
- Aldosterone
- Hypertension
- Cardiovascular Events
- Glucocorticoid
- Mineralocorticoid Receptor
- Adrenal Vein Sampling
- Spironolactone Therapy
- Metabolic Syndrome
- Renal Injury
- Research works
- 50k fractional, since 1950
- In the world top 10%
- 8.7k per year above
- Top-10% rate
- 17.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- -2% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Hormonal Regulation and Hypertension research?
By volume, the United States and China publish the most (1.4k and 810 works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.4k works
- 2 China 810 works
- 3 Japan 327 works
- 4 India 222 works
- 5 Italy 220 works
- 6 United Kingdom 209 works
- 7 Germany 200 works
- 8 Spain 143 works
- 9 France 138 works
- 10 Russia 127 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Hormonal Regulation and Hypertension research?
By volume in 2022–2025, University of Michigan publishes the most Hormonal Regulation and Hypertension research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Brigham and Women's Hospital.
By volume, 2022–2025
- 1 University of MichiganUnited States 30 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 29 works
- 3 Brigham and Women's HospitalUnited States 28 works
- 4 University of PaduaItaly 22 works
- 5 InsermFrance 19 works
- 6 Mayo Clinic in ArizonaUnited States 19 works
- 7 Harvard UniversityUnited States 18 works
- 8 University of KentuckyUnited States 17 works
- 9 Vanderbilt University Medical CenterUnited States 16 works
- 10 University of PennsylvaniaUnited States 15 works
Who are the leading researchers in Hormonal Regulation and Hypertension?
The most-cited researchers publishing on Hormonal Regulation and Hypertension include Giuseppe Remuzzi, Luigi Ferrucci and Winfried März.
- 1 Giuseppe Remuzzi Italy 8.1k citations
- 2 Luigi Ferrucci United States 5.3k citations
- 3 Winfried März Germany 5.2k citations
- 4 Maciej Banach Poland 5.2k citations
- 5 Aletta E. Schutte South Africa 4.6k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Hormonal Regulation and Hypertension research done?
The largest centres of Hormonal Regulation and Hypertension research in 2022–2025 are Beijing (China), Tokyo (Japan), Paris (France) and Boston (United States). Among places with at least 20 works in it, it is an unusually large share of all research in New Orleans.
Largest cities, 2022–2025
Where it is the local speciality
- New OrleansUS · 20.8 works7.7×
Location quotient: how much more of its research is in Hormonal Regulation and Hypertension than the world average.
Where is the best place to study Hormonal Regulation and Hypertension?
Among universities, judged by research, Medical University of Warsaw, University of Turin and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Medical University of WarsawPoland | 62.3 | 20.3% | 11.2× | 13 | +125.9% |
| 2 | University of TurinItaly | 56.7 | 33.5% | 5.0× | 13 | +2.0% |
| 3 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 55.1 | 17.9% | 5.7× | 30 | +33.7% |
| 4 | Karolinska InstitutetSweden | 51.8 | 31.6% | 3.9× | 9 | +6.9% |
| 5 | Chongqing Medical UniversityChina | 50.1 | 17.9% | 8.1× | 14 | +48.3% |
| 6 | Oita UniversityJapan | 50.0 | 12.6% | 30.9× | 9 | +139.7% |
| 7 | University of MichiganUnited States | 48.3 | 16.0% | 4.1× | 30 | +1.6% |
| 8 | Tulane UniversityUnited States | 47.5 | 13.6% | 10.2× | 14 | -46.2% |
| 9 | Harvard UniversityUnited States | 46.7 | 23.6% | 2.6× | 18 | +1.7% |
| 10 | Medical College of WisconsinUnited States | 46.6 | 17.5% | 9.3× | 13 | -39.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Hormonal Regulation and Hypertension research growing?
Output in 2018–2022 was 2% lower than in 2013–2017, peaking in 2025. The fastest-growing topics are Hormonal Regulation and Hypertension.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.